Jin-xin Bei
State Key Laboratory Of Oncology In South China
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
Corrigendum to Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma.
Journal: The Journal of clinical investigation
Published: August 03, 2026
Corrigendum to Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis.
Journal: The Journal of clinical investigation
Published: August 03, 2026
Multimodal spatial profiling reveals distinct myeloid-defined ENKTL subgroups and tumor-myeloid cooperativity within prognostic inflammatory niche.
Journal: Leukemia
Published: April 22, 2026
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Final Results of a Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 19, 2026
SDC1+ CAFs secreting CTGF drive tumour metastasis via FGFR3 signalling in cancers.
Journal: Gut
Published: November 18, 2025
POSTN+ cancer-associated fibroblasts forming fortress-like barrier to mediate immunotherapy resistance in colorectal cancer.
Journal: Cancer letters
Published: September 03, 2025
BCAT1-elicited branched-chain amino acid catabolism fosters neutrophil-mediated pan-metastasis in pancreatic cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 03, 2025
Epstein-Barr virus drives nasopharyngeal carcinoma metastasis via RNA m5C modification of ICAM-1 mediated by NSUN2 and YBX3.
Journal: Cell death and differentiation
Published: June 05, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.
Journal: Cancer discovery
Published: April 02, 2025
CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2025
CLPTM1L interacts with ERLIN2 to stabilize SREBP1 and drive tumorigenesis in nasopharyngeal carcinoma.
Journal: Cell death & disease
Published: October 24, 2024
Last Updated: 09/26/2026